GOKAL, R. Peritoneal dialysis: Prevention and control of infection. Drug Ag.,
v.17, n.4, p. 269-282, 2000.
HEKKING, L.H.P.; ZAREIE, M.; DRIESPRONG, B.A.; FAICT, D.; WELTEN,
A.G.A.; GREEUW, de I.; SCHADEE-EESTERMANS, I.L.; HAVENITH,
C.E.G.; VAN DE BORN, J.; WEE, P.M.T.; BEELEN, R.H.J. Better
preservation of peritoneal morphologic features and defense in rats after
long-term exposure to a bicarbonate/lactate-buffered solution. J. Am. Soc.
Nephrol., v.12, n.12, p.2775-2786, 2001.
JIMÉNEZ-HEFFERNAN, J.A.; BAJO, M.; PERNA, C.; DEL PESO, G.;
LARRUBIA, J.R.; GAMALLO, C.; SÁNCHEZ-TOMERO, J.A.; LÓPEZ-
CABRERA, M.; SELGAS, R. Mast cell quantification in normal peritoneum
and during peritoneal dialysis treatment. Arch. Pathol. Lab. Med., v. 130, n.8,
p.1188-1192, 2006.
JONASSON, P; BRAIDE, M. A commercially available PD fluid with pH and
low GPD induces different morphological changes of rat peritoneum in
intermittent PD. Adv. Perit. Dial., v.14, p.48-53, 1998.
JORRES, A.; BENDER, T.O.; FINN, A.; WITOWSKI, J.; FRÖHLICH, S.;
GAHL, G.M.; FREI, U.; KECK, H.; DEETJEN-PASSLICK, J. Biocompatibility
and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on
peritoneal cell function. Kidney Int., v.54, n.6, p.2184-2193, 1998.
KAPPAS, A.M.; FATOUROS, M.; PAPADIMITRIOU, K.;
KATSOUYANNOPOULOS, V.; CASSIOUMIS, D. Effect of intraperitoneal
saline irrigation at different temperatures on adhesion formation. Br. J. Surg.,
v. 75, n.9, p.854-856, 1988.
KIM, C.D.; KWON, H.; PARK, S.; OH, E.; KIM, M.; CHOI, S.; CHOI, M.; KIM,
I.; PARK, M.; KIM, Y.; KIM, Y. Effects of low glucose degradation products
peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a
chronic rat model. Ther. Aph. Dial., v.11, n.1, p.56-64, 2007.
LAMEIRE, N.; BIESEN, W.V.; LANDSCHOOT, M.V.; WANG, T.;
HEIMBÜRGER, O.; BERGSTRÖM, J.; LINDHOLM, B.; HEKKING, L.P.H.;
HAVENITH, C.E.G.; BEELEN, R.H.J.. Experimental models in peritoneal
dialysis: A European experience. Kidney Int., v.54, n.6, p.2194-2206, 1998.